Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 11, 2013
Capsugel scientists will present and discuss innovative drug delivery technologies that can efficiently address some of the industry’s most pressing formulation and development challenges during the American Association of Pharmaceutical Scientists (...
read more
Monday, November 11, 2013
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has entered into a services agreement with CatScI Ltd. (www.catsci.com), a UK-based ...
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Wednesday, November 06, 2013
Almac have completed a $2m investment programme which doubles its global API and drug product stability storage capacity in line with its growth forecast.
read more
Wednesday, November 06, 2013
The strategies and timing of outsourcing pharmaceutical development processes to a contract testing laboratory will be the focus of a mini-workshop at the 2013 AAPS Annual Meeting and Exposition on Nov. 12, 2013.
read more
Monday, November 04, 2013
BioStorage Technologies, a global provider of comprehensive sample
management solutions for the bioscience industry, announced today that through its partnership with the BGI-Shenzhen, the company will provide technical consulting services to the ...
read more
Monday, November 04, 2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), today officially opens its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia. The facility was ...
read more
Thursday, October 31, 2013
“The launch of the new brand logo is an outward sign of an important transformation that’s been ongoing for the past couple of years,” said John D. Bucksath, President and CEO. “The entire organization has worked very hard to get where we are today. ...
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
Thursday, October 24, 2013
In Jan 2013, Almac completed the doubling of their pharmaceutical development service capabilities with the opening of a new dedicated Non-GMP facility together with 2 analytical laboratories at their UK headquarters.
read more
Tuesday, October 22, 2013
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, is delighted to announce its new collaboration with Almac, to provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic...
read more
Thursday, October 17, 2013
Almac has today announced the launch of a new offering for the provision of [14C]-labelled Antibody Drug Conjugates (ADCs).
read more
Tuesday, September 24, 2013
BioOutsource Ltd. (“BioOutsource”), a leading international Contract Testing Organization (CTO) has consolidated its position as the leading expert in the biological analysis of Biosimilar Monoclonal Antibodies for the biopharmaceutical industry. ...
read more
Friday, September 20, 2013
Coldstream Laboratories, Inc., a provider of parenteral manufacturing and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development. In this position, Ms. Savoy will be ...
read more